Sign up to access historical data
Similar companies
| Company | Est. Transaction Value | |
|---|---|---|
 |
Union PacificUNP |
-$26,000 |
 |
FedExFDX |
$73,000 |
 |
UPSUPS |
-$190,000 |
 |
XPO LogisticsXPO |
$8,000 |
 |
Ardmore ShippingASC |
-$1,000 |
Trades by US Politicians
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Kevin Hern | Oct 28, 2025 | Sell | $15K - $50K |
| Val Hoyle | Sep 23, 2025 | Sell | $1K - $15K |
| Jefferson Shreve | May 12, 2025 | Sell | $15K - $50K |
| Bruce Westerman | Apr 21, 2025 | Sell | $1K - $15K |
| Jefferson Shreve | Apr 17, 2025 | Buy | $15K - $50K |
| Bruce Westerman | Apr 8, 2025 | Buy | $1K - $15K |
| Rob Bresnahan | Apr 8, 2025 | Sell | $1K - $15K |
| Jefferson Shreve | Mar 13, 2025 | Sell | $15K - $50K |
| Rob Bresnahan | Feb 25, 2025 | Sell | $1K - $15K |
| Ro Khanna | Nov 15, 2024 | Buy | $1K - $15K |
| Daniel Newhouse Republican | Apr 10, 2024 | Buy | $1K - $15K |
| Thomas Tuberville Republican | Mar 12, 2024 | Sell | $15K - $50K |
FAQ - Congress Trading
Kevin Hern sold CSX shares most recently on October 28, 2025.
Jefferson Shreve has bought the most CSX stock in the last 2 years, with an estimated value of $33,000.
Jefferson Shreve has sold the most CSX stock in the last 2 years, with an estimated value of $66,000.
The net value of trades by US politicians for CSX in the last 2 years is negative, amounting to -$110,000. This suggests that US politicians do not believe in the success of the company for various reasons.
Over the last 2 years, insider transactions for CSX have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering politicians might have insights or reasons not immediately apparent to the public.
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.
